ESC Premium Access

Differential benefit of statin in secondary prevention of acute myocardial infarction according to the level of triglyceride and high-density lipoprotein cholesterol

Presentation

26 more presentations in this session

Effects of statin therapy on plasma proprotein convertase subtilisin/kexin type 9 and sortilin levels in statin-naive patients with coronary artery disease

Speaker: Doctor T. Nozue (Yokohama, JP)

Thumbnail

Is routine combination of renin-angiotensin system blocker and beta blocker beneficial in low-risk myocardial infarction patients?

Thumbnail

Renalguard to prevent acute kidney injury in high risk patients undergoing coronary interventions

Speaker: Doctor V. Gritti (Cinisello Balsamo, IT)

Thumbnail

Benefit of early statin initiation within 48 hours after admission in patients with acute myocardial infarction

Speaker: Associate Professor M. Kim (Gwangju, KR)

Thumbnail

Prescription of statins and one year risk of major clinical outcomes among ACS patients with extremely low LDL-c (<70mg/dl): data from CPACS studies

Speaker: Doctor Y. Sun (Beijing, CN)

Thumbnail

Access the full session

Poster session 6 - Adjunctive medical therapy in coronary artery disease

Speakers: Doctor T. Nozue, Doctor V. Gritti, Associate Professor M. Kim, Doctor Y. Sun
Thumbnail

About the event

Image

ESC CONGRESS 2016

27 August - 31 August 2016

Sessions Presentations

This platform is supported by

logo Novo Nordisk